Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
4,080,222
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
348,140
-
Shares change
-
+14,490
-
Total reported value, excl. options
-
$6,148,038
-
Value change
-
+$252,272
-
Number of buys
-
8
-
Number of sells
-
6
-
Price
-
$17.66
Institutional Holders of vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) as of Q2 2024
As of 30 Jun 2024 vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 348,140 shares of stock of the company.
Largest 10 holders included Samsara BioCapital, LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, UBS Group AG, BlackRock Inc., MORGAN STANLEY, Planning Capital Management Corp, Strengthening Families & Communities, LLC, and OSAIC HOLDINGS, INC..
This table shows 24 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.